News
Vamousse™ head lice treatment coming to Walmart stores in the USA
14 January 2014
TyraTech, Inc. (AIM: TYR and TYRU) a life sciences company focusing on nature-derived insect and parasite control products, is pleased to announce its head lice treatment product, Vamousse™, will come to Walmart stores in the USA from the end of March 2014.
The USA market for head lice control products is estimated by TyraTech as being worth approximately $150 million per annum. Given the superior efficacy and safety of Vamousse™, TyraTech believes it is in a position to achieve strong penetration of this market for its breakthrough head lice product, reinforcing their confidence in meeting market expectations for 2014 revenues.
Bruno Jactel, Chief Executive Officer, said: "I am delighted to report that TyraTech's breakthrough technology and innovative products are capturing the attention of major retailers. This is our most important milestone to date as it will significantly raise the profile of TyraTech's brands in the US, helping us further expand our market penetration and market share. In addition, the fact that Vamousse™ will come to Walmart stores reinforces our strategy of establishing our own brands within the market place.
This is an exciting development for TyraTech and we look forward to the future with great confidence."
Further information on Vamousse™ is available on the Company's website at: http://www.tyratech.com/content/company-products/head-lice.asp
For further information please contact:
| TyraTech Inc. Alan Reade, Non-Executive Chairman Bruno Jactel, Chief Executive Officer |
Tel: +44 7841978709 Tel: +1 919 415 4340 |
| SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady |
Tel: +44203 368 3551 |
| Allenby Capital Limited , Joint Broker Chris Crawford |
Tel: 44 20 3328 5656 |
| Walbrook, Financial PR and IR Bob Huxford /Guy McDougall (Public Relations) Paul Cornelius (Investor Relations) |
Tel: +44 20 7933 8792 Tel: +44 20 7933 8794 |
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.